Cargando...
How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases has become a focus of clinical interest because the NTRK genes (NTRK1-3) encoding them have been identified as oncogenic fusion genes in a wide range of different tumor types, including lung cancer. These NTRK gene fusions usu...
Guardado en:
| Publicado en: | Transl Lung Cancer Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815373/ https://ncbi.nlm.nih.gov/pubmed/33489816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-434 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|